提高18F-FDG-PET/CT对非小细胞肺癌区域淋巴结受累诊断效能的研究
本研究纳入2016年6月至2018年8月间经EBUS-TBNA及18F-FDG-PET/CT检查的非小细胞肺癌患者113例共321枚淋巴结,比较纵隔血池活性阈值与另外5项PET/CT参数对淋巴结转移的诊断效能。结果显示纵隔血池阈值敏感度97.4%、特异度35.8%;淋巴结SUVmax阈值3.9时敏感度90.9%、特异度61.9%,淋巴结/纵隔血池SUVmax比值阈值1.7时敏感度90.9%、特异度60.7%。作者认为采用较高的淋巴结/纵隔血池SUVmax比值阈值及其他PET/CT变量可提高诊断效能,在保持高敏感度的同时改善特异度。
要点
- 纵隔血池活性阈值诊断淋巴结转移敏感度97.4%但特异度仅35.8%,阴性预测值97.8%。
- 淋巴结SUVmax阈值3.9时敏感度90.9%、特异度61.9%,较纵隔血池阈值特异度提高。
- 淋巴结/纵隔血池SUVmax比值阈值1.7时敏感度90.9%、特异度60.7%。
核心结论
- 与纵隔血池阈值相比,采用较高的淋巴结/纵隔血池SUVmax比值阈值及其他PET/CT变量可提高PET/CT对非小细胞肺癌淋巴结分期的诊断效能,尤其在保持高敏感度的同时改善特异度。
研究设计与样本
- 回顾性纳入2016年6月至2018年8月间诊断为非小细胞肺癌并接受EBUS-TBNA及18F-FDG-PET/CT检查的患者113例,共321枚经病理取样的淋巴结。
- 以病理组织学结果为参考标准,进行基于淋巴结站和基于淋巴结分期的分析,比较纵隔血池阈值与另外5项PET/CT参数(淋巴结SUVmax、淋巴结/纵隔血池SUVmax比值、淋巴结/肿瘤SUVmax比值、淋巴结短轴直径、淋巴结SUVmax/短轴直径比值)。
- 各PET/CT参数的最佳阈值通过受试者工作特征曲线分析确定。
诊断标准与关键数值
- 纵隔血池活性阈值:敏感度97.4%、特异度35.8%、阳性预测值32.8%、阴性预测值97.8%。
- 淋巴结SUVmax阈值3.9:敏感度90.9%、特异度61.9%。
- 淋巴结/纵隔血池SUVmax比值阈值1.7:敏感度90.9%、特异度60.7%。
临床应用与阅片要点
- 在非小细胞肺癌淋巴结分期阅片时,除纵隔血池活性阈值外,可参考淋巴结SUVmax及淋巴结/纵隔血池SUVmax比值等定量参数。
- 纵隔血池阈值具有高敏感度和高阴性预测值,但特异度较低,需结合其他PET/CT参数综合判断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To assess the diagnostic performance of combined 2-[18F]-fluoro-2-deoxy-d-glucose (18F-FDG) positron-emission tomography (PET)/computed tomography (CT) mediastinal blood pool (MBP) activity cut-off for staging nodal involvement, and to examine other variables that may improve the diagnostic performance of PET/CT in non-small cell lung cancer (NSCLC).
MATERIALS AND METHODS: All patients diagnosed with NSCLC who underwent endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and 18F-FDG-PET/CT between June 2016 and August 2018 were included. Nodal station and nodal staging-based analyses were performed, comparing the MBP cut-off and five other PET/CT parameters (node maximum standardised uptake value [SUVmax], node/MBP SUVmax ratio, node/tumour SUVmax ratio, node short axis diameter, and node SUVmax/node short axis diameter ratio) with histopathology results. The optimal cut-off value for each PET/CT parameter was determined using receiver operating characteristic curve analysis.
RESULTS: One hundred and thirteen patients with a total of 321 nodes with pathological sampling were included. Nodal activity above MBP on PET/CT demonstrated 97.4% sensitivity, 35.8% specificity, 32.8% positive predictive value, and 97.8% negative predictive value. Of the five other PET/CT parameters examined, the two most promising were node SUVmax and node/MBP SUVmax. The node SUVmax cut-off of 3.9 demonstrated 90.9% sensitivity and 61.9% specificity, and the node/MBP SUVmax cut-off of 1.7 demonstrated 90.9% sensitivity and 60.7% specificity.
CONCLUSION: Compared to the MBP cut-off, use of a higher node/MBP SUVmax ratio cut-off and use of other PET/CT variables can improve the diagnostic performance of PET/CT for NSCLC nodal staging. In particular, specificity for detecting malignant nodal involvement is improved while maintaining high sensitivity.
引用
- Yang DD, Mirvis E, Goldring J, et al. Improving diagnostic performance of 18F-FDG-PET/CT for assessment of regional nodal involvement in non-small cell lung cancer. Clin Radiol. 2019. PMID: 31420186. doi:10.1016/j.crad.2019.07.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。